Physician profile
Gary Goykhman
NPI 1588663470
$11,368.97
in general payments reported to CMS, 2019-2025
29 companies · $1,510 in 2025
The $1,510 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,283 · 2020: $753 · 2021: $1,650 · 2022: $2,584 · 2023: $950 · 2024: $638 · 2025: $1,510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,563 · Travel and Lodging: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,562.62 |
| Travel and Lodging | $536.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Edge Orthopaedics, INC. | $3,158.37 | 2019-2023 | |
| Stryker Corporation | $1,898.77 | 2019-2025 | Salvation, Hoffmann, Ortholoc 3di |
| Arthrex, INC. | $1,547.40 | 2019-2025 | |
| Paragon 28, INC. | $1,454.29 | 2020-2025 | Trauma |
| Wright Medical Technology, INC. | $679.78 | 2019 | |
| Treace Medical Concepts, INC. | $374.28 | 2024-2025 | |
| Innovation Technologies INC | $299.97 | 2023 | Irrisept |
| Horizon Therapeutics Plc | $295.50 | 2019-2020 | |
| Tei Medical INC. | $257.51 | 2019 | |
| Organogenesis INC. | $220.77 | 2019-2025 | Nushield, Puraply Wound Matrix |
| Smith+Nephew, INC. | $188.21 | 2019-2024 | Evos Mini, Ilizarov, Maverick |
| Trice Medical, INC. | $153.78 | 2023 | |
| Royal Biologics, INC. | $138.27 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $132.51 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $121.84 | 2025 | Exparel |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Embody, INC. | $73.53 | 2021 | |
| Access Pro Medical, LLC | $70.62 | 2025 | Matriderm |
| Djo, LLC | $64.62 | 2025 | Cmf |
| Integra Lifesciences Corporation | $49.20 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acumed LLC | $22.11 | 2020 | |
| Zimmer Biomet Holdings, INC. | $21.04 | 2019 | |
| Ani Pharmaceuticals, INC. | $20.35 | 2022 | |
| Merck Sharp & Dohme LLC | $19.88 | 2019 | |
| Kerecis Limited | $19.88 | 2021 | |
| Kci USA, INC. | $19.40 | 2021 | |
| Anika Therapeutics, INC. | $19.23 | 2021 | |
| Depuy Synthes Sales INC. | $18.00 | 2025 | N/A |
| Medtronic, INC. | $15.90 | 2023 | Venaseal |
| Amgen INC. | $13.96 | 2025 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Goykhman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.